RI
BLTE

RTW Investments’s Belite Bio BLTE Stock Holding History

RTW Investments’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$114M Hold
715,332
– – 1.13% 28
2025
Q4 		$114M Buy
715,332
+402,832
+129% +$47.7M 1.15% 26
2025
Q3 		$23.1M Buy
+312,500
New +$20.5M 0.28% 53

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

RTW Investments's BLTE Position: Q1 2026 in Review

RTW Investments held its Belite Bio (BLTE) position steady in Q1 2026 at 715,332 shares worth $114M. The position accounts for 1.13% of the portfolio, ranked #28.

RTW Investments first reported a position in BLTE in Q3 2025 and has held it in 3 quarters since. The position peaked at $114M in Q4 2025. 75 funds tracked by Wall St. Rank hold BLTE as of Q1 2026.

  • RTW Investments held 715,332 shares of Belite Bio worth $114M as of Q1 2026.
  • RTW Investments left its Belite Bio share count unchanged in Q1 2026.
  • Belite Bio made up 1.13% of RTW Investments's portfolio in Q1 2026, its #28 holding.
  • RTW Investments first reported a position in Belite Bio in Q3 2025 and has held it in 3 quarters since.
  • RTW Investments's Belite Bio position peaked at $114M in Q4 2025.
  • 75 funds tracked by Wall St. Rank held Belite Bio as of Q1 2026.

Based on RTW Investments's 13F filing for Q1 2026, filed 15 May 2026.